英文名稱 | Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) |
---|---|
中文名稱 | 德喜曲妥珠單抗 | 德盧替康-曲妥珠單抗 |
CAS號 | 1826843-81-5 |
儲存條件 | store at -20°C |
英文名稱 | Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) |
---|---|
中文名稱 | 德喜曲妥珠單抗 | 德盧替康-曲妥珠單抗 |
CAS號 | 1826843-81-5 |
儲存條件 | store at -20°C |
Trastuzumab Deruxtecan (Enhertu) is a HER2-targeting ADC combining a humanized anti-HER2 antibody with a topoisomerase I inhibitor, deruxtecan (DXd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer.
PMID: 33473250 PMCID: PMC7797586 DOI: 10.1177/1758835920986518
Cancer Sci. 2020 Dec;111(12):4636-4645.
PMID: 31574081 PMCID: PMC6772042 DOI: 10.1371/journal.pone.0222280